Announcements Trials
Browse Landscape

Phase

Phase 3 13Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 24INDUSTRY 4NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Head & Neck 1

Conditions

Salivary Gland Neoplasms 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasms 1Breast Cancer Invasive Nos 1Adenocarcinoma 1

Interventions

Cisplatin 118Radiotherapy 114Cyclophosphamide 93Paclitaxel 84Gemcitabine 74Carboplatin 67Filgrastim 60Doxorubicin 57Vincristine 56Etoposide 56Docetaxel 56Fluorouracil 51Cytarabine 41Prednisone 40Methotrexate 40Leucovorin 39Dexamethasone 37Capecitabine 36Irinotecan 35Rituximab 29Oxaliplatin 28Granulocyte Colony-Stimulating Factor 27Cetuximab 26Bevacizumab 26durvalumab 24Temozolomide 24Radiotherapy, Intensity-Modulated 24Peripheral Blood Stem Cell Transplantation 24Magnetic Resonance Spectroscopy 24Surgical Procedures, Operative 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × NETWORK × Triptorelin Pamoate × Clear all
NCT05896566 2026-02-24

PREcoopERA

ETOP IBCSG Partners Foundation

Phase 2 Completed
231 enrolled
Breast

Breast Neoplasms

NCT01969578 2024-11-05

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
149 enrolled
Head & Neck

Adenocarcinoma, Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02005887 2019-05-29

TREND

ETOP IBCSG Partners Foundation

Phase 2 Completed
51 enrolled 10 charts
Breast

Breast Cancer Invasive Nos

Data powered by HemOnc (CC BY 4.0) Colophon âš¡